Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 30.35% vs 26.75% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 38.61% vs 36.74% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 63.93% vs 47.07% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 33.18% vs 44.57% in Mar 2024
Compare Profit and Loss Results of Fredun Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
453.00
462.00
-9.00
-1.95%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
453.00
462.00
-9.00
-1.95%
Expenditure (Ex Depriciation)
Stock Adjustments
6.00
-10.00
16.00
160.00%
Raw Materials Consumed
321.00
317.00
4.00
1.26%
Power & Fuel Cost
4.00
5.00
-1.00
-20.00%
Employee Cost
22.00
52.00
-30.00
-57.69%
Operating Expenses
14.00
2.00
12.00
600.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
5.00
34.00
-29.00
-85.29%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
4.00
-2.00
-50.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
401.00
409.00
-8.00
-1.96%
Operating Profit (PBDIT) excl Other Income
52.00
53.00
-1.00
-1.89%
Other Income
2.00
17.00
-15.00
-88.24%
Operating Profit (PBDIT)
55.00
70.00
-15.00
-21.43%
Interest
22.00
0.00
22.00
0%
Profit before Depriciation and Tax
32.00
69.00
-37.00
-53.62%
Depreciation
4.00
5.00
-1.00
-20.00%
Profit Before Taxation & Exceptional Items
28.00
64.00
-36.00
-56.25%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
28.00
64.00
-36.00
-56.25%
Provision for Tax
7.00
15.00
-8.00
-53.33%
Profit After Tax
20.00
48.00
-28.00
-58.33%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
43.00
102.00
-59.00
-57.84%
Profit Available for appropriations
64.00
151.00
-87.00
-57.62%
Appropriations
64.00
151.00
-87.00
-57.62%
Equity Dividend (%)
7%
0%
7.00
Earnings Per Share
44.83
0.57
44.26
7,764.91%
Profit And Loss - Net Sales
Net Sales 453.82 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 30.35% vs 26.75% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 52.65 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 38.61% vs 36.74% in Mar 2024
Profit And Loss - Interest
Interest 22.38 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 63.93% vs 47.07% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 20.81 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 33.18% vs 44.57% in Mar 2024






